These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37404482)

  • 1. Evaluation of Renal Function Profile in Human Visceral Leishmaniasis (Kala-Azar) Patients: A Case of Western Tigray, Ethiopia.
    Asfaw KG; Gizaw ST; Gnanasekaran N
    Res Rep Trop Med; 2023; 14():21-33. PubMed ID: 37404482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study.
    Tesfanchal B; Gebremichail G; Belay G; Gebremariam G; Teklehaimanot G; Haileslasie H; Kahsu G; Gebrewahd A; Mardu F; Adhanom G; Berhe B; Teame H; Tsegaye A; Wolde M
    Infect Drug Resist; 2020; 13():3055-3062. PubMed ID: 32943889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.
    Endale HT; Mengstie TA; Dawit DD; Mohammed R; Dessie G; Tesfa KH
    PLoS One; 2021; 16(11):e0260022. PubMed ID: 34797863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
    Mondal D; Ghosh P; Chowdhury R; Halleux C; Ruiz-Postigo JA; Alim A; Hossain F; Khan MAA; Nath R; Duthie MS; Kroeger A; Matlashewski G; Argaw D; Olliaro P
    Front Microbiol; 2019; 10():2268. PubMed ID: 31649631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis treatment outcome and its determinants in northwest Ethiopia.
    Welay GM; Alene KA; Dachew BA
    Epidemiol Health; 2016; 39():e2017001. PubMed ID: 28092934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.
    Hailu W; Mohamed R; Fikre H; Atnafu S; Tadesse A; Diro E; van Grienvsen J
    PLoS One; 2021; 16(6):e0252419. PubMed ID: 34101727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trend prevalence of visceral Leishmaniasis in West Armachiho District, Amhara Region, Northwest Ethiopia.
    Gize A; Workineh A; Hailu T
    Trop Dis Travel Med Vaccines; 2020 Nov; 6(1):23. PubMed ID: 33292689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological, clinical and hematological profiles of visceral leishmaniasis among patients visiting Tefera Hailu Memorial Hospital, Northeast Ethiopia: a 4 year retrospective study.
    Debash H; Bisetegn H; Nigatie M; Abeje G; Feleke DG
    Sci Rep; 2023 Jan; 13(1):931. PubMed ID: 36650391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?
    Muniaraj M
    Trop Parasitol; 2014 Jan; 4(1):10-9. PubMed ID: 24754021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone Use Evaluation in Western Zone Tigray Hospitals, Ethiopia: A Retrospective Cross-Sectional Study.
    Shegute T; Hiruy M; Hadush H; Gebremeskel L
    Biomed Res Int; 2023; 2023():7688896. PubMed ID: 38027045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
    Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human visceral leishmaniasis in kermanshah province, Western iran, during 2011-2012.
    Hamzavi Y; Hamzeh B; Mohebali M; Akhoundi B; Ajhang Kh; Khademi N; Ghadiri K; Bashiri H; Pajhouhan M
    Iran J Parasitol; 2012; 7(4):49-56. PubMed ID: 23323091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.
    Alemayehu M; Wubshet M; Mesfin N; Tamiru A; Gebayehu A
    Health Qual Life Outcomes; 2017 Aug; 15(1):65. PubMed ID: 28851361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of visceral leishmaniasis: a case control study in north-western Ethiopia.
    Yared S; Deribe K; Gebreselassie A; Lemma W; Akililu E; Kirstein OD; Balkew M; Warburg A; Gebre-Michael T; Hailu A
    Parasit Vectors; 2014 Oct; 7():470. PubMed ID: 25312308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.